These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 17956498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R, Basco LK.
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
    Nsimba B, Jafari-Guemouri S, Malonga DA, Mouata AM, Kiori J, Louya F, Yocka D, Malanda M, Durand R, Le Bras J.
    Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [Abstract] [Full Text] [Related]

  • 6. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
    Omar SA, Mens PF, Schoone GJ, Yusuf A, Mwangi J, Kaniaru S, Omer GA, Schallig HD.
    Exp Parasitol; 2005 May; 110(1):73-9. PubMed ID: 15804381
    [Abstract] [Full Text] [Related]

  • 7. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
    Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, Egwang TG, D'Alessandro U.
    Infect Genet Evol; 2004 Dec; 4(4):321-7. PubMed ID: 15374529
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
    Mockenhaupt FP, Teun Bousema J, Eggelte TA, Schreiber J, Ehrhardt S, Wassilew N, Otchwemah RN, Sauerwein RW, Bienzle U.
    Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
    [Abstract] [Full Text] [Related]

  • 10. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
    Gebru-Woldearegai T, Hailu A, Grobusch MP, Kun JF.
    Am J Trop Med Hyg; 2005 Dec; 73(6):1131-4. PubMed ID: 16354825
    [Abstract] [Full Text] [Related]

  • 11. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
    Biswas S.
    J Postgrad Med; 2004 Dec; 50(1):17-20. PubMed ID: 15047993
    [Abstract] [Full Text] [Related]

  • 12. Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.
    Cohuet S, Bonnet M, Van Herp M, Van Overmeir C, D'Alessandro U, Guthmann JP.
    Am J Trop Med Hyg; 2006 Jul; 75(1):152-4. PubMed ID: 16837723
    [Abstract] [Full Text] [Related]

  • 13. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M, Barreto Miranda I, Schunk M, Maduhu I, Maboko L, Hoelscher M, Berens-Riha N, Kitua A, Löscher T.
    Malar J; 2007 Jan 15; 6():2. PubMed ID: 17224049
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Rønn AM.
    Am J Trop Med Hyg; 2003 Dec 15; 69(6):601-6. PubMed ID: 14740875
    [Abstract] [Full Text] [Related]

  • 16. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ.
    J Infect Dis; 2008 Jun 01; 197(11):1605-13. PubMed ID: 18471066
    [Abstract] [Full Text] [Related]

  • 17. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
    Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G.
    Am J Trop Med Hyg; 2003 Sep 01; 69(3):247-52. PubMed ID: 14628939
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
    Eriksen J, Mwankusye S, Mduma S, Kitua A, Swedberg G, Tomson G, Gustafsson LL, Warsame M.
    Trans R Soc Trop Med Hyg; 2004 Jun 01; 98(6):347-53. PubMed ID: 15099990
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.